home / stock / hook / hook news

HOOK News and Press, HOOKIPA Pharma Inc. From 03/19/20

Stock Information
Company Name: HOOKIPA Pharma Inc.
Stock Symbol: HOOK
Market: NASDAQ
Website: hookipapharma.com
Menu
HOOK HOOK Quote HOOK Short HOOK News HOOK Articles HOOK Message Board
Get HOOK Alerts

News, Short Squeeze, Breakout and More Instantly...
HOOK - HOOKIPA Pharma Inc. (HOOK) CEO Joern Aldag on Q4 2019 Results - Earnings Call Transcript

HOOKIPA Pharma Inc. (HOOK) Q4 2019 Earnings Conference Call March 19, 2020, 08:00 AM ET Company Participants Matthew Beck - Executive Director, Investor Relations Joern Aldag - CEO Reinhard Kandera - CFO Igor Matushansky - CMO Roman Necina - CTO Conference Call Participant...
HOOK - HOOKIPA Pharma EPS misses by $0.29, beats on revenue

HOOKIPA Pharma (NASDAQ: HOOK ): Q4 GAAP EPS of -$0.40 misses by $0.29 . More news on: HOOKIPA Pharma Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HOOK - HOOKIPA Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Provides a Corporate Update

NEW YORK and VIENNA, Austria, March 19, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today reports its fina...

HOOK - HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020

NEW YORK and VIENNA, Austria, March 10, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that i...
HOOK - HOOKIPA Pharma to Present at SVB Leerink 9th Annual Global Healthcare Conference

NEW YORK and VIENNA, Austria, Feb. 18, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HO...

HOOK - 2 Small-Cap Biotech Stocks to Watch in 2020

Small-cap biotech stocks have consistently been one of the best-performing groups of equities for almost 10 straight years. The advent of several game-changing technologies, broader access to healthcare globally, and an aging population in the United States have all helped to boost valuations am...

HOOK - HOOKIPA's Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

NEW YORK and VIENNA, Austria, Jan. 06, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that HO...
HOOK - Hookpia doses first patient in mid-stage HB-201 study

HOOKIPA Pharma (NASDAQ: HOOK ) doses first patient in a Phase 1/2 clinical trial (NCT04180215) of HB-201, an immunotherapy for the treatment of Human Papillomavirus 16-positive (HPV16 + ) cancers. This trial is HOOKIPA’s first clinical trial in immuno-oncology. More news on: HOO...

HOOK - HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers

NEW YORK and VIENNA, Austria, Dec. 30, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that th...

HOOK - Sizing Up Hookipa Pharma

No matter how much falls on us, we keep plowing ahead. That's the only way to keep the roads clear. "― Greg Kincaid Today we take a look at a ' Tier 4 ' developmental concern that came public in the second quarter of this year. The stock has had a big rally recently but is still ...
Previous 10 Next 10